Cannabis Bioscience International Holdings (CBIH) Gross Margin (2022 - 2025)
Historic Gross Margin for Cannabis Bioscience International Holdings (CBIH) over the last 7 years, with Q3 2025 value amounting to 66.35%.
- Cannabis Bioscience International Holdings' Gross Margin fell 289700.0% to 66.35% in Q3 2025 from the same period last year, while for Aug 2025 it was 73.11%, marking a year-over-year decrease of 141700.0%. This contributed to the annual value of 86.76% for FY2025, which is 50900.0% up from last year.
- Cannabis Bioscience International Holdings' Gross Margin amounted to 66.35% in Q3 2025, which was down 289700.0% from 87.0% recorded in Q2 2025.
- In the past 5 years, Cannabis Bioscience International Holdings' Gross Margin ranged from a high of 95.33% in Q3 2024 and a low of 29.9% during Q1 2025
- For the 4-year period, Cannabis Bioscience International Holdings' Gross Margin averaged around 69.74%, with its median value being 81.65% (2023).
- Its Gross Margin has fluctuated over the past 5 years, first skyrocketed by 214700bps in 2024, then crashed by -974700bps in 2025.
- Cannabis Bioscience International Holdings' Gross Margin (Quarter) stood at 91.41% in 2022, then dropped by -17bps to 76.33% in 2023, then rose by 17bps to 89.49% in 2024, then decreased by -26bps to 66.35% in 2025.
- Its Gross Margin was 66.35% in Q3 2025, compared to 87.0% in Q2 2025 and 29.9% in Q1 2025.